Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$421M |
| 2 |
Ovintiv
OVV
|
+$348M |
| 3 |
Halliburton
HAL
|
+$296M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$184M |
| 5 |
Las Vegas Sands
LVS
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$492M |
| 2 |
IBM
IBM
|
+$394M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$334M |
| 4 |
Costco
COST
|
+$283M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.88% |
| 2 | Healthcare | 12.75% |
| 3 | Consumer Discretionary | 12.46% |
| 4 | Communication Services | 11.43% |
| 5 | Technology | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wells Fargo
WFC
$254B
| $2.26B | 7.31% |
41,205,254
-4,025,360
| -9% | -$213M |
|
|
BNY
2
Bank of New York Mellon
BNY
$108B
| $2.23B | 7.2% |
54,870,475
-7,017,351
| -11% | -$275M |
|
3
American Express
AXP
$227B
| $2.07B | 6.7% |
22,239,723
-2,293,821
| -9% | -$206M |
|
4
Alphabet (Google) Class C
GOOG
$4.18T
| $1.99B | 6.44% |
75,572,496
-3,285,376
| -4% | -$88.2M |
|
|
5
Berkshire Hathaway Class A
BRK.A
$1.06T
| $1.47B | 4.77% |
6,518
-1,543
| -19% | -$334M |
|
|
6
Amazon
AMZN
$2.79T
| $1.45B | 4.69% |
93,407,800
+26,997,680
| +41% | +$421M |
|
7
Liberty Global Class C
LBTYK
$3.55B
| $1.26B | 4.09% |
32,361,993
+4,209,245
| +15% | +$154M |
|
8
UnitedHealth
UNH
$350B
| $1.16B | 3.75% |
11,461,371
-1,812,135
| -14% | -$172M |
|
|
ESRX
9
DELISTED
Express Scripts Holding Company
ESRX
| $1.1B | 3.56% |
13,002,699
+2,352,174
| +22% | +$184M |
|
|
10
Las Vegas Sands
LVS
$30.5B
| $844M | 2.73% |
14,517,719
+2,832,030
| +24% | +$171M |
|
11
CarMax
KMX
$8.82B
| $781M | 2.53% |
11,726,913
+458,902
| +4% | +$25.4M |
|
|
PX
12
DELISTED
Praxair Inc
PX
| $704M | 2.28% |
5,433,852
-38,109
| -0.7% | -$4.83M |
|
13
JPMorgan Chase
JPM
$935B
| $694M | 2.25% |
11,096,430
+10,315
| +0.1% | +$621K |
|
14
Texas Instruments
TXN
$241B
| $664M | 2.15% |
12,427,196
-30,521
| -0.2% | -$1.54M |
|
|
15
Costco
COST
$420B
| $641M | 2.07% |
4,522,761
-2,080,485
| -32% | -$283M |
|
16
Labcorp
LH
$27.3B
| $640M | 2.07% |
6,901,208
-70,896
| -1% | -$6.26M |
|
|
SCHW
17
Charles Schwab
SCHW
$194B
| $587M | 1.9% |
19,451,228
-239,729
| -1% | -$6.81M |
|
|
18
Ovintiv
OVV
$18.5B
| $545M | 1.76% |
7,860,732
+4,083,068
| +108% | +$348M |
|
19
PACCAR
PCAR
$69B
| $545M | 1.76% |
12,009,746
-118,819
| -1% | -$5.13M |
|
20
Visa
V
$693B
| $505M | 1.63% |
7,706,452
-18,620
| -0.2% | -$1.12M |
|
21
Bausch Health
BHC
$2.41B
| $502M | 1.62% |
3,508,163
-21,074
| -0.6% | -$2.83M |
|
22
Ecolab
ECL
$78.9B
| $457M | 1.48% |
4,374,165
+112,056
| +3% | +$12.3M |
|
23
Sysco
SYY
$40.2B
| $423M | 1.37% |
10,654,643
+127,175
| +1% | +$4.93M |
|
24
Booking.com
BKNG
$158B
| $403M | 1.3% |
8,825,650
-62,000
| -0.7% | -$2.8M |
|
25
Chubb
CB
$132B
| $385M | 1.25% |
3,353,376
-15,811
| -0.5% | -$1.75M |
|
Similar funds
Christopher Davis's Q4 2014 Portfolio in Review
As of Q4 2014, Christopher Davis held 201 positions worth $30.9B, down 4% from $32.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Christopher Davis withdrew a net $2.37B in Q4 2014, closing 10 positions and reducing 105 holdings. Its most notable exit was Monsanto Co, an estimated $208M position sold in full.
By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Christopher Davis opened a new position in Keysight worth $49.9M.
- Christopher Davis's largest Q4 2014 buy was Keysight: 1,476,620 shares worth $49.9M.
- Christopher Davis added most to Amazon in Q4 2014, an estimated $421M increase.
- Christopher Davis's biggest Q4 2014 reduction was Canadian Natural Resources, cutting an estimated $492M.
- Christopher Davis fully exited Monsanto Co in Q4 2014, selling an estimated $208M.
- Christopher Davis's ten largest holdings make up 51% of its $30.9B portfolio in Q4 2014.
- Christopher Davis opened 13 new positions and closed 10 in Q4 2014.
- Christopher Davis's portfolio value fell 4% quarter-over-quarter to $30.9B.
Based on Davis Selected Advisers's 13F filing for Q4 2014, filed 11 Feb 2015.